Canopy Growth (CGC) Change in Inventory (2019 - 2025)
Canopy Growth (CGC) reported Change in Inventory of $6.3 million for Q4 2025, up 820.81% on a YoY basis from $681488.4 in Q4 2024, and up 406.37% sequentially from -$2.0 million in Q2 2025.
Canopy Growth (CGC) Change in Inventory (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Change in Inventory data on file, last reported at $6.3 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory rose 820.81% year-over-year to $6.3 million; the trailing twelve-month figure through Dec 2025 stood at $8.5 million (up 215.98% YoY), and the FY2026 full-year result was -$2.7 million, down 121.91% from the prior year.
- Change in Inventory improved to $6.3 million in Q4 2025, from -$2.0 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $14.8 million in Q2 2021 to a low of -$155.9 million in Q1 2022.
- A 5-year average of -$12.2 million and a median of -$491925.9 in 2023 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory tumbled 657.8% in 2022 and jumped 820.81% in 2025, its largest moves.
- Tracing CGC's Change in Inventory over 5 years: stood at -$8.0 million in 2021, then surged by 122.79% to $1.8 million in 2022, then soared by 52.75% to $2.8 million in 2023, then slumped by 75.63% to $681488.4 in 2024, then jumped by 820.81% to $6.3 million in 2025.
- Business Quant data shows CGC's Change in Inventory at $6.3 million in Q4 2025, -$2.0 million in Q2 2025, and $681488.4 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.28 Mn |
| Dec 31, 2025 | 6.28 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Dec 31, 2024 | 681,488.38 |
| Dec 31, 2024 | 681,488.38 |
| Sep 30, 2024 | 3.64 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.12 Mn |
| Mar 31, 2024 | -6.74 Mn |
| Mar 31, 2024 | -6.74 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Jun 30, 2023 | -1.67 Mn |
| Jun 30, 2023 | -1.67 Mn |
| Mar 31, 2023 | -50.69 Mn |
| Mar 31, 2023 | -50.69 Mn |